Objective: To characterize the oral bacterial microbiome in HIV-infected participants at baseline and after 24 weeks of EFV/FTC/TDF.
Introduction
Opportunistic oral infections are common among persons living with HIV (PLWH), and have been linked to deteriorating immune function, weight loss and poor nutrition [1] [2] [3] . Even in the current antiretroviral therapy (ART) era, oral candidiasis, HIV salivary disease, human papilloma virus (HPV)-associated oral lesions, xerostomia and ulcerations are frequently reported [4] . Periodontal disease, also commonly seen in PLWH, contributes to cardiometabolic diseases [5, 6] . In a prospective cohort of PLWH, an increase in periodontal disease was associated with increases in carotid artery intima-media thickness, a surrogate measure of atherosclerosis [7] . This highlights the need to characterize the oral microbiome in the setting of HIV infection and ART initiation.
The microbiome of the oral cavity is distinct from that found in the nares, skin and gastrointestinal tract [8] . Notably, the oral cavity presents a niche with high-alpha diversity but the low-beta diversity, that is, the oral cavity is a very diverse environment in terms of absolute bacterial diversity but that these communities are quite similar between individuals, remaining stable in both short-term and long-term longitudinal assessments [9, 10] . Furthermore, in longitudinal analyses, whenever variability exists in the microbial phyla that are present in the oral cavity, active metabolic pathways remain conserved indicating functional stability in the oral microbiome [8] .
The oral microbiome has been primarily studied in periodontal disease and its link to systemic diseases such as cardiovascular disease (CVD) and arthritis [11] . In periodontal disease, overgrowth of pathogenic bacteria (e.g. Fusobacteria spp., Prevotella spp. and Porphyromonas spp.) has been hypothesized to induce endotoxemia and resultant systemic inflammation [12, 13] . Recurrent exposure to endotoxin in animal models results in increased mortality and cardiac fibrosis [14] . In the FINRISK cohort, an HIV-negative cohort, high-antibody response to periodontal pathogens predicted CVD events [15] . These data suggest a link between oral bacterial communities and systemic disease; however, a full understanding has yet to be defined, particularly in PLWH.
Previous studies have indicated that the oral microbiome may be altered by HIV infection or ART, although results are highly variable, with different species associated with HIV infection, including increases in Streptococcus spp. in some studies and decreased in others [16] [17] [18] [19] [20] [21] . Similarly, ART has been associated with variable changes [22, 23] . Other components of the microbiome, including the mycobiome and virome have been less well characterized. Fungal colonization is also altered demonstrating increased Candida spp. with HIV [17, 22, 24] , and HPV DNA was increased after 24 weeks of ART [25] . Although intriguing, these studies are limited by small sample size, variations in technique and their mostly cross-sectional nature. The enteric microbiome demonstrates significant interindividual and intraindividual variability [26] , as well as significant variability associated with genetics, diet, sexual activity and season [27] [28] [29] 30] . Because of this, longitudinal studies of the changes in the microbiome associated with changes in health in an individual may provide better information than crosssectional studies comparing PLWH to unrelated, uninfected controls. The objective of our study was to explore changes in the oral microbiome data from 35 HIV-infected persons over a 24-week period following initiation of therapy with efavirenz, emtricitabine and tenofovir (EFV/FTC/TDF).
Methods

Study cohort
Samples were collected from participants co-enrolled in two AIDS Clinical Trials Group (ACTG) studies, A5272 (NCT01029249) and A5280 (NCT01403051) [25, 31] . A5280 was a randomized-placebo controlled study in which ART-naïve participants initiated ART with EFV/ FTC/TDF. A5272 was a prospective, observational study of HIV-1 infected ART-naive adults (!18 years old) designed to collect throat wash and saliva specimens and evaluate changes in HPV oral shedding and the incidence of oral warts following ART initiation. For the present analysis, we obtained samples from all participants who had available paired samples from both visits as well as complete biomarker datasets. Saliva samples (70 samples from 35 participants) met these criteria and were used for this study. The protocol was approved by the institutional review boards of all participating sites. All participants provided written informed consent.
Biomarker assays HIV-1 RNA and CD4 þ T-cell counts were performed at local CLIA-certified laboratories. Serum samples were stored at À70 8C until batched analysis at the Irving Institute Biomarkers Core at Columbia University Medical Center (New York, New York, USA) as part of the A5280 study [31] . We measured IL-6 (ELISA; R&D Systems, Minneapolis, Minnesota, USA); soluble receptors of TNFa (sTNFr-I and sTNFr-II; ELISA; R&D Systems), and soluble CD14 þ (sCD14, ELISA; R&D Systems).
16S rRNA gene sequencing and analyses Bar-coded PCR primers directed at the V4 region of the bacterial 16S rRNA gene were used to generate amplicons from nucleic acid isolated from saliva samples [32] . Multiplex sequencing of amplicons with samplespecific barcodes was performed using an Illumina MiSeq instrument (paired end 2x250 nt reads).
Demultiplexing of 16S rRNA gene sequences was performed in QIIME (Quantitative Insights Into Microbial Ecology, v.1.8.0) [33] (Full commands in Supplementary Information). Read quality control and the resolution of amplicon sequence variants (ASV) were completed using the DADA2 R package (v.1.5.2) [34] . Ten low quality 5 0 bases of the forward read and 50 3 0 bases of the reverse read were removed following inspection of quality control plots. All sequences with any Ns, reads mapping to phiX and reads with a maximum expected error greater than 2 following truncation were also removed. Error estimation was calculated on all samples (pooled) following dereplication. Following chimera removal (consensus method), taxonomy was assigned independently to the RDP v.14 16S rRNA gene sequence database [35] . Additional species level assignment to the RDP species training sets was accomplished using the addSpecies function of DADA2. Blastn against the NCBI 16S reference database was used to further define the taxonomy of selected ASV. ASV were aligned using the R MSA package [36] and arranged into a maximum likelihood phylogeny (GTR model with optimization of the proportion of invariable sites and the gamma rate parameter) using the phangorn package [37] . The resulting phylogenetic tree was combined with the table of ASVand merged with sample data for loading into the PhyloSeq package [38] . Full details of the DADA2 workflow are available at https://github.com/shandley/ HIV-Oral in the file HIV_oral_16S_preprocessing.Rmd.
Samples with fewer than 50 ASV were removed. ASV not assigned to the kingdom bacteria or assigned to the mitochondrial family or chloroplast class were also removed. PhyloSeq was used to calculate alpha diversity measures of richness and Shannon Diversity and beta diversity using weighted UniFrac on log transformed counts [39] . Permutational multivariate analysis of variance of the distance matrices between groups were compared using ADONIS from the R package vegan [40] . Differential abundance testing of taxa between groups was completed using the DeSeq2 algorithm using a beta prior and Wald's significance test with local fitting of dispersion [41] . Random forest classification was implemented using the random Forest R package (citation: https://cran.r-project.org/web/packages/randomForest/citation.html). Taxa-specific plots were generated using rlog normalized data. Intrasample and intersample distance comparisons were calculated using Hellinger transformed data on Euclidian distances using the vegdist function in the R package vegan [40] . Full details of the DADA2 workflow are available at https:// github.com/shandley/HIV-Oral in the file HIV_oral_a-nalysis.Rmd
Statistical analysis
Descriptive data characteristics were used to summarize the cohort. Continuous variables were summarized using median and inter-quartile range (IQR); categorical variables were summarized using frequency and percentage (%). Spearman's rank correlations were used to examine bivariate associations between study variables. Fisher's exact and chi-square tests were used to compare categorical variables between the study groups. 
Results
Cohort characteristics
The study participants were predominantly men (88.6%); 45.7% white, 31.4% African American, and 20% Hispanic, with a median age of 36 years (range: 19-61). The median CD4 þ T-cell count was 326 cells/ml (range: 7-804), with five participants having entry CD4 þ T-cell counts less than 200 cells/ml (herein CD4 þ low vs. CD4 þ high if CD4 þ T-cell counts !200 cells/ml; Table 1 ). None had opportunistic infections within the past 30 days, and none were coinfected with tuberculosis or HCV. Although CD4 þ T-cell counts increased in all participants, three participants still had CD4 þ T-cell counts less than 200 cells/ml at the week 24 time point ( Figure S1A , http://links.lww.com/QAD/B252). The median viral load was 30 136 copies/ml (range: 1091-1 614 781 copies/ml); nine participants had baseline viral load greater than 100 000 copies/ml (herein viral load high vs. viral load if < 100 000 copies/ml; Figure S1B , http://links.lww.com/QAD/B252). All participants achieved virologic suppression by week 12, although one participant rebounded to 9100 copies/ml at week 24.
Effects of antiretroviral therapy on the salivary bacterial microbiome The bacterial microbiome was characterized using 16S rRNA gene profiling. Sequencing resulted in an average of 4070 ASV per sample (SD: 4901.82) ( Figure S2 , http://links.lww.com/QAD/B252). Similar to previous Changes in the oral microbiome with ART Presti et al. 1281 reports, at baseline the most abundantly detected bacterial phyla in the salivary microbiome were Bacteroidetes, Firmicutes and Proteobacteria, with lower relative abundance of Fusobacteria, Spirochaetes, Actinobacteria, and Ternericutes (Fig. 1a) . Following 24 weeks of ART, the dominant phyla represented in the saliva remained similar to that found at baseline (Fig. 1b) . There was no significant difference in beta diversity whenever comparing baseline samples to those collected following 24 weeks of ART (Fig. 1c , ADONIS test P value: 0.744). However, the communities within each participant did change over time (Fig. 1c) . Similarly, alpha diversity (richness and . 1d ). On average, the bacterial communities became more similar across all participants following 24 weeks of ART (Fig. 1d) .
Detection of differentially abundant ASV between baseline samples and samples collected following 24 weeks of ART yielded only two discriminatory sequences ( Fig. 2a and Table S1 , http://links.lww.com/QAD/ B253). A sequence with only 91% identity to Muribaculum intestinale (log 2 fold change ¼ À4.193) was more frequently detected (Fisher's exact test P value ¼ 0.0005) in baseline samples, although the average abundance was not significantly different (Fig. 2b) . Treponema lecithinolyticum (log 2 fold change ¼ 2.848) was detected at similar frequencies, but was on average more abundant in week 24 samples (Fig. 2c) . Of note, the 91% sequence similarity to M. intestinale suggests that this is a novel representative of the phylum Bacteroidetes, family Porphyromonadaceae which is not currently in sequence databases.
Effects of CD4 R T-cell count and HIV viral load on the salivary microbiome
To determine the effect of CD4 þ T-cell counts on the salivary bacterial microbiome, we compared these measurements to the alpha and beta diversity as well as determined differentially abundant taxa between participants with CD4 þ low (< 200 cells/ml) vs. CD4 þ high (!200 cells/ml) at both sampling time points. At baseline, both the number of bacterial taxa detected and the average alpha diversity of samples at baseline were not significantly different ( Figure S6a and c, http://links. lww.com/QAD/B252). However, following 24 weeks of ART, samples obtained from the three participants who had persistently low CD4 þ T-cell counts had significantly higher bacterial richness (P ¼ 0.0007) and Shannon diversity (P ¼ 0.0053) whenever compared with those with CD4 þ T-cell counts that remained or recovered to greater than 200 cells/ml ( Figure S6b and ( Fig. 3a and Table S2 , http://links.lww.com/QAD/ B254). This ASV was more abundant in baseline CD4 þ high samples (log 2 fold change ¼ 3.149). After further investigation, this sequence was found to increase in abundance following 24 weeks of ART specifically in the CD4 þ low-participant samples (Fig. 3b) . The abundance was significantly higher in CD4 þ high samples than CD4 þ low samples at baseline, and switched to be more abundant in CD4 þ low samples than CD4 þ high samples following 24 weeks of ART.
In participants with viral load less than 100 000 copies/ml at baseline, the numbers of detectable bacterial taxa following 24 weeks of ART treatment were significantly reduced whenever compared with their paired baseline samples, although the bacterial diversity was similar in both groups ( Figure S5 , http://links.lww.com/QAD/ B252). No statistically significant differences were detected in alpha diversity measures at baseline or following 24 weeks of ART whenever comparing participants with viral load less than 100 000 copies/ml to those with viral load at least 100 000 copies/ml ( Figure  S4 , http://links.lww.com/QAD/B252). There were no significant differences between viral load high and viral load low groups at baseline as determined by the ADONIS test (P value ¼ 0.632). It was not possible to calculate significance in viral load group differences in samples collected following 24 weeks of ART as no participants had a high viral load at that time point. There were no discriminatory differentially abundant taxa identified whenever comparing viral load groups at baseline or following 24 weeks of ART.
Effect of demographic data on the salivary bacterial microbiome In order to determine if demographic parameters had an effect on the bacterial microbiome, we tested for significant group differences in bacterial communities between groups using the ADONIS test. Testing for significance between sex, ethnicity and race failed to identify any significant differences (ADONIS P value at baseline: race ¼ 0. The salivary bacterial microbiome as a discriminating feature of antiretroviral therapy and CD4 R T-cell count Inflammatory biomarkers changed variably with ART ( Figure S7 , http://links.lww.com/QAD/B252). We implemented a random forest classification scheme to determine the contribution of inflammatory biomarkers (IL-6, sTNFr-I, sTNFr-II, sCD14), virologic (HIV-1 viral load), and bacterial microbiome (richness and diversity) parameters in classifying participants' CD4 þ category (CD4 þ low vs. CD4 þ high) both pre-ARTand post-ART. Prior to ART, the most important factor for categorizing CD4 þ category was sTNFr-II followed by viral load (Fig. 4a) . However, following 24 weeks of ART, the most important factors for CD4 þ category classification became the alpha diversity of the salivary microbiome (Fig. 4b) .
Discussion
We report on the effect of 24 weeks of ART with EFV/ FTC/TDF on the oral bacterial microbiome in HIVinfected participants. Key strengths of the current study include prospective data collection, uniform ART Comparison of ASV with 100% identity to Haemophilus parainfluenzae identified with differential abundance testing. Differences between groups were considered statistically significant if P less than 0.05 using the nonparametric Kruskal-Wallis Test correcting for multiple comparisons using the method of Benjamini, Krieger and Yekutieli. Ã P 0.05, ÃÃ P 0.01. FDR, false discovery rate.
therapy given to all participants and longitudinal sample collection from baseline and following 24 weeks of ART using individuals as their own controls. Our study is limited by a lack of HIV-negative controls. Given significant individual variability, the best control samples would be taken from participants prior to acquisition of HIV. As all participants are HIV-infected, our study evaluates the effect of both HIV control and ART on the salivary microbiome.
Most prior studies of the oral microbiome were designed as cross-sectional studies comparing HIV-infected participants with HIV-negative controls [16] [17] [18] [19] [20] [21] [22] [23] [24] . Only two studies evaluated longitudinal changes after ART administration, with conflicting findings as one demonstrated and increase and the other a decrease in the prevalence of Aggregatibacter after ART administration [22, 23] . These studies differed in methodology from our study, in that the microbiome was assessed using culture techniques. Regardless, these studies suggest that HIVand ART drive changes in specific bacterial taxa in the oral microbiome. Many of these are associated with periodontal disease and should be considered in the pursuit of developing treatments to minimize HIVassociated periodontal disease.
We did not observe a characteristic shift in diversity after ART initiation, but did see substantial change in individual participant salivary bacterial community structures between the baseline and after treatment. When comparing participants with high baseline CD4 þ T-cell count or low baseline viral load, we demonstrate a relative decrease in richness after 24 weeks of ART, similar to prior reports [22] . In participants with low CD4 þ T-cell count, we demonstrate an increase in bacterial alpha diversity associated with the elimination of viremia. Taken together, these data suggest that alpha diversity is associated with both low CD4 þ T-cell counts and low HIV load, with immune reconstitution and viral suppression correlated with decreases in bacterial diversity. The variability of these individual responses may reflect changes induced by (1) immune reconstitution, (2) a direct influence of the ART used (EFV/FTC/ TDF) or (3) a shift in the microbiome reflective of the individual prior to HIV infection. It is difficult to differentiate between these possibilities without an uninfected control group, preinfection samples, samples from participants treated with other ART regimens or a well matched untreated control group. We identified two differentially abundant ASV between baseline and week 24 samples. One sequence was more frequently detected in baseline samples, and is most closely related to an enteric bacterium of mice, M. intestinale. The low percentage identity (91%) demonstrates that this ASV is distinct from M. intestinale but likely belongs to a member of the Porphyromonadaceae. Porphyromonadaceae have been associated with the human oral cavity, and are important periodontal pathogens [8] . Without specific taxonomic assignment, it is unclear why this bacteria is specifically associated with oral microbiomes of PLWH prior to ART, however, it is a specific bacterial marker as it is almost entirely absent following 24 weeks of ART. Our finding is similar to prior findings that among participants with untreated HIV, there is an overgrowth of Porphyromonas [12, 13] . The second ASV was associated with the salivary bacterial microbiome in samples collected after 24 weeks of ART. This sequence has 100% identity to T. lecithinolyticum, a Spirochaete also implicated causing periodontal disease [42] . These findings could partially explain the ongoing incidence of periodontal disease in treated PLWH [43] .
Changes in the oral microbiome with ART Presti et al. 1285 At baseline, an ASV with 100% identity to Haemophilus parainfluenzae presence is noted to discriminate between high and low CD4 þ groups. H. parainfluenzae was ubiquitous in both CD4 þ high and low groups. Its abundance was not significantly changed in CD4 þ high samples, but increased in CD4 þ low samples following 24 weeks of ART, suggesting that immunodeficiency is associated with low abundance of H. parainfluenzae, which is then restored to normal or higher levels following ART.
Further analysis demonstrated that the CD4 þ T-cell count classification of participants prior to ART initiation is most related to viral load and inflammatory cytokines. After suppression of viremia, features of the microbiome, including richness and diversity, play a more prominent role in CD4 þ T-cell count. These limited data raise the intriguing possibility that persistent changes in the microbiome may play a role in CD4 þ T-cell count recovery, and suggest that measurement of salivary bacterial diversity could serve as a biomarker of immune reconstitution following ART.
In conclusion, these data suggest that the oral microbiome is highly variable from person to person, with some shifts toward more similarity after 24 weeks of ART with virologic suppression. This may be because of a variety of factors, including antibiotic administration, immune compromise, oral disease or differences in oral care. The expression of these bacterial communities may also lead to further immune activation, as microbial translocation from the oral cavity may contribute to microbial translocation and systemic immune activation, similar to what has been postulated in the lower gastrointestinal tract. Future studies should address how the microbiome shifts during the complex time period after ART initiation. These studies should incorporate data about immune function and inflammation, as well as control for ART regimen, the passage of time and the extensive variety of factors, which are known to influence the microbiome.
